Meridian Bioscience Stock To Go Ex-dividend Tomorrow (VIVO)

NEW YORK ( TheStreet) -- The ex-dividend date for Meridian Bioscience (Nasdaq: VIVO) is tomorrow, February 1, 2012. Owners of shares as of market close today will be eligible for a dividend of 19 cents per share. At a price of $16.87 as of 9:30 a.m. ET, the dividend yield is 4.3%.

The average volume for Meridian Bioscience has been 225,500 shares per day over the past 30 days. Meridian Bioscience has a market cap of $817 million and is part of the health care sector and drugs industry. Shares are down 8.2% year to date as of the close of trading on Monday.

Meridian Bioscience, Inc., a life science company, engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for gastrointestinal, foodborne, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products primarily consist of C. The company has a P/E ratio of 25.5, below the average drugs industry P/E ratio of 30.5 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Meridian Bioscience as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and premium valuation. You can view the full Meridian Bioscience Ratings Report.

See our dividend calendar or top-yielding stocks list.
null

If you liked this article you might like

3 Undiscovered, Undervalued Health Care Stocks Poised to Outperform the Sector in 2016

Insider Trading Alert - VIVO, CCG And PDCE Traded By Insiders

Meridian Bioscience (VIVO) Weak On High Volume

Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom

Meridian Bioscience (VIVO) Upgraded From Hold to Buy